Detecting SARS-CoV-2 Orf3a and E ion channel activity in COVID-19 blood samples
Abstract Background: SARS-CoV-2 has been found in the heart of COVID-19 patients. It is unclear how the virus passes from the upper respiratory tract to the myocardium. We hypothesized that SARS-CoV-2 is present in the blood of COVID-19 infected patients, spreading to other organs such as heart....
Main Authors: | Han-Gang Yu, Gina Sizemore, Katy Smoot, Peter Perrotta |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-01-01
|
Series: | Journal of Clinical and Translational Science |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S2059866121008566/type/journal_article |
Similar Items
-
Inhibition of SARS-CoV-2 Viral Channel Activity Using FDA-Approved Channel Modulators Independent of Variants
by: Han-Gang Yu, et al.
Published: (2022-11-01) -
The SARS-CoV-2 accessory protein Orf3a is not an ion channel, but does interact with trafficking proteins
by: Alexandria N Miller, et al.
Published: (2023-01-01) -
SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence
by: Sameer Mohammad, et al.
Published: (2020-08-01) -
Performance of Dried Blood Spot Samples in SARS-CoV-2 Serolomics
by: Rima Jeske, et al.
Published: (2022-06-01) -
The changing profile of SARS-CoV-2 serology in Irish blood donors
by: Dermot Coyne, et al.
Published: (2023-12-01)